Skip to main content
SpringerLink
Log in

Acute antiinflammatory and gastric effects of the seleno-organic compound ebselen

  • Inflammation and Immunomodulation
  • Published:
Agents and Actions Aims and scope Submit manuscript

Abstract

Ebselen (2-phenyl-1,2-benzisoselenazol-3(2H)-one), a seleno-organic compound with glutathione peroxidase-like activityin vitro, was compared with indometacin, BW 755C, and levamisole as an inhibitor of carrageenan- and CVF (cobra venom factor)-induced paw oedema in the rat. The antiinflammatory potency of ebselen against CVF-induced oedema (ED50=56 mg/kg p.o.) was similar to that of BW 755C, while indometacin was weakly active in this model, and levamisole exerted stronger activity. In the carrageenan model, ebselen exhibited weak inhibitory potency, like BW 755C, while indometacin markedly inhibited this inflammatory response, and levamisole was inactive. Unlike cyclooxygenase inhibitors, ebselen produced almost no gastric irritation in rats up to 316 mg/kg p.o. Moreover, ebselen inhibited significantly diclofenac-induced gastric intolerance at 31.6 and 316 mg/kg p.o. Thus, ebselen represents a new tool for antiinflammatory therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. C. V. Wedmore and T. J. Williams,Control of vascular permeability by polymorphonuclear leucocytes in inflammation. Nature289, 646–650 (1981).

    Article  PubMed  Google Scholar 

  2. J. C. Fantone and P. A. Ward,Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions. Am. J. Pathol.107, 397–418 (1982).

    Google Scholar 

  3. K. Ley and K.-E. Arfors,Changes in macromolecular permeability by intravascular generation of oxygen-derived free radicals. Microvasc. Res.24, 25–33 (1982).

    Article  PubMed  Google Scholar 

  4. R. M. McMilland and S. J. Foster,Leukotriene B 4 and inflammatory disease. Agents and Actions24, 114–119 (1988).

    PubMed  Google Scholar 

  5. A. Müller, E. Cadenas, P. Graf and H. Sies,A novel biologically active seleno-organic compound — I. Glutathione peroxidase-like activity in vitro and antioxidant capacity of PZ 51 (ebselen). Biochem. Pharmac.33, 3235–3239 (1984).

    Article  Google Scholar 

  6. A. Wendel, M. Fausel, H. Safayhi, G. Tiegs and R. Otter,A novel biologically active seleno-organic compound. — II. Activity of PZ 51 in relation to glutathione peroxidase. Biochem. Pharmac.33, 3241–3245 (1984).

    Article  Google Scholar 

  7. M. J. Parnham and S. Kindt,A novel biologically active seleno-organic compound — III. Effects of PZ 51 (ebselen) on glutathione peroxidase and secretory activities of mouse macrophages. Biochem. Pharmac.33, 3247–3250 (1984).

    Article  Google Scholar 

  8. P. Kuhl, H. O. Borbe, H. Fischer, A. Römer and H. Safayhi.Ebselen reduces the formation of LTB 4 in human and porcine leucocytes by isomerisation to its 5S,12R-6-trans-isomer, Prostaglandins31, 1029–1048 (1986).

    Article  PubMed  Google Scholar 

  9. S. Ichikawa, K. Omura, T. Katayama, N. Okamura, T. Ohtsuka, S. Ishibashi and H. Masayasu,Inhibition of superoxide anion production in guinea pig polymorphonuclear leucocytes by a seleno-organic compound, ebselen. J. Pharmacobio-Dyn.10, 595–597 (1987).

    PubMed  Google Scholar 

  10. I. Cotgreave, S. K. Duddy, G. E. N. Kass, D. Thompson and P. Moldéus,Studies on the anti-inflammatory activity of ebselen. Ebeselen interferes with granulocyte oxidative burst by dual inhibition of NADH oxidase and protein kinase C? Biochem. Pharmac.38, 649–656 (1989).

    Article  Google Scholar 

  11. M. J. Parnham, S. Leyck, N. Dereu, J. Winkelmann and E. Graft,Ebselen (PZ 51): A GSH-peroxidase-like organoselenium compound with anti-inflammatory activity. Adv. Inflamm. Res.10, 398–400 (1986).

    Google Scholar 

  12. A. Wendel and G. Tiegs,A novel biologically active seleno-organic compound — VI. Protection by ebselen (PZ 51) against galactosamine/endotoxin-induced hepatitis in mice. Biochem. Pharmac.35, 2115–2118 (1986).

    Article  Google Scholar 

  13. M. J. Parnham, S. Leyck, P. Kuhl, J. Schalkwijk and W. B. van den Berg,Ebselen: A new approach to the inhibition of peroxidase-dependent inflammation. Int. J. Tiss. React.9, 45–50 (1987).

    Google Scholar 

  14. H. P. Hartung, B. Schäfer, K. Heininger and K. V. Toyka,Interference with arachidonic acid metabolism suppresses experimental allergic neuritis. Ann. Neurol.20, 168 (1986).

    Google Scholar 

  15. I. A. Cotgreave, U. Johansson, G. Westergren, P. W. Moldéus and R. Brattsand,The anti-inflammatory activity of ebselen but not thiols in experimental alveolitis and bronchiolitis. Agents and Actions24, 313–319 (1988).

    PubMed  Google Scholar 

  16. K. Stockhaus and H. Wick,Die Sekretion von Saft- und Säuremengen bei Ratten mit unterbundenem Pylorus (Shay-Ratten). Arzneim.-Forsch.20, 856–858 (1970).

    Google Scholar 

  17. S. Leyck, E. Etschenberg, U. Hadding and J. Winkelmann,A new model of acute inflammation: Cobra venom factor induced paw oedema. Agents and Actions13, 437–438 (1983).

    Google Scholar 

  18. C. A. Winter, E. A. Risley and G. W. Nuss,Carrageenin-induced edema in hind paw of the rat as an assay for anti-inflammatory drugs. Proc. Soc. Exp. Biol. Med.111, 544–547 (1962).

    Google Scholar 

  19. S. Leyck, N. Dereu, E. Etschenberg, M. Ghyczy, E. Graf, J. Winkelmann and M. J. Parnham,Improvement of the gastric tolerance of non-steroidal anti-inflammatory drugs by polyene phosphatidylcholine (Phospholipon® 100). Eur. J. Pharmacol.117, 35–42 (1985).

    Article  PubMed  Google Scholar 

  20. R. Vinegar, J. F. Truax, J. L. Selph, A. Lea and P. R. Johnston,Quantitative in vivo studies of the acute actions of anti-inflammatory drugs in the rat. Eur. J. Rheumatol. Inflammation1, 204–211 (1978).

    Google Scholar 

  21. S. T. Hoffstein, R. M. Manzi, K. A. Razgaitis, P. E. Bender and J. Gleason,Structural requirements for chemotactic activity of leukotriene B 4 (LTB 4). Prostaglandins31, 205–215 (1986).

    Article  PubMed  Google Scholar 

  22. H. Safayhi, G. Tiegs and A. Wendel,A novel biologically active seleno-organic compound — V. Inhibition by ebselen (PZ 51) of rat peritoneal neutrophil lipoxygenase. Biochem. Pharmac.34, 2691–2694 (1985).

    Article  Google Scholar 

  23. D. K. Imagawa, N. E. Osifchin, W. A. Paznekes, M. L. Shin and M. M. Mayer,Consequences of cell membrane attack by complement: Release of arachidonate and formation of inflammatory derivatives. Proc. Natl. Acad. Sci.80, 6647–6651 (1983).

    PubMed  Google Scholar 

  24. T. Sacks, C. F. Moldow, P. R. Craddock, T. K. Bowers and B. S. Jacob,Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes: An in vitro model of immune vascular damage. J. Clin. Invest.61, 1161–1167 (1978).

    PubMed  Google Scholar 

  25. G. A. Higgs, J. A. Salmon, B. Henderson and J. R. Vane,Pharmacokinetics of aspirin and salicylate in relation to inhibition of arachidonate cyclooxygenase and anti-inflammatory activity. Proc. Natl. Acad. Sci. USA84, 1417–1420 (1987).

    PubMed  Google Scholar 

  26. S. Abramson, H. M. Korchak, R. Ludewig, H. Edelson, K. Haines, R. Levin, R. Herman, L. Rider, S. Kimmel and G. Weissmann,Modes of action of aspirin-like drugs. Proc. Natl. Acad. Sci. USA82, 7227–7231 (1985).

    PubMed  Google Scholar 

  27. A Lorico, P. Masturzo, S. Villa, M. Salmona, N. Semeraro and G. de Gaetano,Gentisic acid: An aspirin metabolite with multiple effects on human blood polymorphonuclear leukocytes. Biochem. Pharmacol.35, 2443–2445 (1986).

    Article  PubMed  Google Scholar 

  28. B. M. Peskar,On the synthesis of prostaglandins by human gastric mucosa and its modification by drugs. Biochim. Biophys. Acta487, 307–314 (1977).

    PubMed  Google Scholar 

  29. U. Aehringhaus, H. Weiler, B. A. Peskar and B. M. Peskar,Molecular mechanism of the gastric toxicity of antirheumatic drugs. Arch. Toxicol.Suppl. 7, 323–327 (1984).

    Google Scholar 

  30. K. D. Rainsford,Mechanisms of gastrointestinal ulceration by nonsteroidal antiinflammatory/analgesic drugs. Adv. Inflam. Res.6, 51–64 (1984).

    Google Scholar 

  31. Y. Kurebayashi, Y. Tabuchi and M. Akasaki,Gastric cytoprotection by ebselen against the injury induced by necrotizing agents in rats. Arzneim.-Forsch./Drug Res.39, 250–253 (1989).

    Google Scholar 

  32. G. Pihan, C. Regillo and S. Szabo,Free radicals and lipid proxidation in ethanol- or aspirin-induced gastric mucosal injury. Digest. Disease Sc.32, 1395–1401 (1987).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Rhône-Poulenc/Nattermann, Cologne Research Centre, Nattermannallee 1, D-5000, Cologne 30, FRG

    S. Leyck & M. J. Parnham

Authors
  1. S. Leyck
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. J. Parnham
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Leyck, S., Parnham, M.J. Acute antiinflammatory and gastric effects of the seleno-organic compound ebselen. Agents and Actions 30, 426–431 (1990). https://doi.org/10.1007/BF01966308

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01966308

Keywords

Search

Navigation